Status:
COMPLETED
Does Oral Propranolol Accelerate Labor Induction/Augmentation With Oxytocin in Nulliparous Women in Abakaliki?
Lead Sponsor:
Darlington-Peter Chibuzor Ugoji
Conditions:
Duration of Labor
Eligibility:
FEMALE
16-45 years
Phase:
NA
Brief Summary
Labour is usually physiologic, spontaneous and progressive, but occasionally, there may be the need for induction or augmentation of labour especially in nulliparous women, who are at increased risk o...
Detailed Description
ABSTRACT Background: Labour is usually physiologic, spontaneous and progressive, but occasionally, there may be the need for induction or augmentation of labour especially in nulliparous women, who ar...
Eligibility Criteria
Inclusion
- Nulliparous women selected for induction or augmentation of labour
- Term pregnancy selected for induction or augmentation of labour
- Normal singleton pregnancies with cephalic presenting foetuses.
- Those who gave their consent.
Exclusion
- Co-existing medical illnesses such as diabetes mellitus, cardiac disease, haemoglobinopathies, renal diseases, hypertensive disease, Bronchial asthma,
- Women currently taking Propranolol or a chronic beta-blocker use
- Contraindications to labour or vaginal delivery
- Multiple gestations
- Preterm labour
- Chorioamnionitis
- Known fetal anomalies
- Abnormal fetal presentation.
- Antepartum haemorrhage.
- Contraindication to induction and augmentation of labour
- Multi-party
- Known allergy to propranolol
Key Trial Info
Start Date :
November 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05251610
Start Date
November 2 2020
End Date
April 30 2021
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AEFUTHA
Abakaliki, Ebonyi State, Nigeria, 234